Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
CONCLUSIONS: Although larger studies are needed to confirm these results, our data open up new ways of investigation into the effects of AIs on QoL in HR+ BC patients.
PMID: 32992318 [PubMed - as supplied by publisher]
Source: Oncology - Category: Cancer & Oncology Authors: Borreani C, Alfieri S, Infante G, Miceli R, Mariani P, Bosisio M, Vernieri C, Bianchi GV, Capri G Tags: Oncology Source Type: research
More News: Anxiety | Breast Cancer | Cancer | Cancer & Oncology | Depression | Hormones | Obsessive Compulsive Disorder | Psychology | Sleep Disorders | Sleep Medicine | Study | Switzerland Health | Tamoxifen | Women